This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Bayer Intellectual Property Gmbh, Bayer Pharma Aktiengesellschaft. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2016
Title: Isabella Gashaw: Innovator in Pharmaceutical Chemistry
Introduction
Isabella Gashaw is a prominent inventor based in Berlin, Germany. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for medical applications. Her work focuses on addressing critical health issues through her patented inventions.
Latest Patents
Isabella Gashaw holds a patent for "Estra-1,3,5(10),16-tetraene-3-carboxamide derivatives, processes for their preparation, pharmaceutical preparations comprising them and their use for preparing medicaments." This invention relates to AKR1C3 inhibitors and outlines processes for their preparation. It also details their use in the treatment and prophylaxis of diseases, particularly bleeding disorders and endometriosis. This patent showcases her commitment to advancing medical science and improving patient outcomes.
Career Highlights
Throughout her career, Isabella has worked with notable companies, including Bayer Intellectual Property GmbH and Bayer Pharma Aktiengesellschaft. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research and development.
Collaborations
Isabella has collaborated with esteemed colleagues such as Matthias Busemann and Oliver Martin Fischer. These partnerships have enriched her work and fostered innovation in her projects.
Conclusion
Isabella Gashaw is a trailblazer in pharmaceutical chemistry, with a focus on developing innovative solutions for pressing medical challenges. Her contributions through patents and collaborations highlight her dedication to improving healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile